Article

의사-제약회사 상호작용이 처방에 미치는 영향

홍진표1, 박상은2, 고윤석3,*
Jin Pyo Hong1, Sang Eun Park2, Younsuck Koh3,*
Author Information & Copyright
1울산의대 서울아산병원 정신과
2안양샘병원 내과
3울산의대 서울아산병원 내과 및 인문사회의학교실
1Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine
2Department of Internal Medicine, Anyang Sam General Hospital
3Department of Medical Humanities & Social Sciences, Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine
*교신저자: 고윤석. 울산대학교 서울아산병원 인문사회의학교실 및 호흡기내과. 02-3010-3134. yskoh@amc.seoul.kr

ⓒ Copyright 2011 The Korean Society for Medical Ethics. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Apr 26, 2011; Accepted: Jun 20, 2011

Published Online: Jun 30, 2011

ABSTRACT

The relationship between the medical profession and the pharmaceutical industry has received considerable attention in recent years in Korea. In this article we examine the impact of physicianpharmaceutical industry interaction (PPII) on physician prescriptions. While physicians’ decisions concerning prescriptions are influenced by many factors, two of the most influential are the visits of sales representatives from pharmaceutical companies and the gifts and other enticements that pharmaceutical companies provide for physicians. Patients regard gifts from pharmaceutical companies as less appropriate and more influential than do physicians. Inappropriate relations between physicians and pharmaceutical companies can damage physician-patient relationships and harm the medical profession as a whole. Recent investigations in the United States and Korea have found many illegalities in physician-pharmaceutical industry interaction. The article argues for the urgent need to develop clear ethical codes and compliance mechanisms concerning PPII.

Keywords: 제약회사-의사 상호관계; 처방; 마케팅
Keywords: physician-pharmaceutical industry interaction; marketing; prescriptions